Where is Cellbyte located?

Cellbyte is headquartered in Munich, Germany.

How many employees does Cellbyte have?

As of Mar 31, 2026, the latest employee count at Cellbyte is 10.

Is Cellbyte a funded company?

Cellbyte is a funded company, having raised a total of $3.25M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of Cellbyte?

Cellbyte's latest funding was a $***** Seed round on Nov 19, 2025, with participation from 5 investors. Its primary sector is Life Sciences Tech. Globally, the Life Sciences Tech sector has seen $6.38B in funding in 2026 to date.

Where does Cellbyte rank among its competitors?

Cellbyte ranks 10th amongst 110 active competitors, of which 23 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Qureight, which secured $20M in Jul, 2026.

Who are the top competitors of Cellbyte?

Cellbyte's top competitors include Manifold AI, Komodo Health and Owkin. Among them, Qureight secured the most recent funding round in July, 2026.

Cellbyte - 2026 Company Profile, Team, Funding & Competitors

Cellbyte is a seed company based in Munich (Germany), founded in 2024 by Samuel Moreira, Felix Steinbrenner and Daniel Moreira. It operates as an AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry. Cellbyte has raised $3.25M in funding from Frontline Ventures. The company has 110 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Manifold AI, Komodo Health and Owkin.

Company Details

AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry. It leverages natural language processing that enables users to extract insights from vast amounts of pharmaceutical data, streamlining the process of launching new drugs.

Website: cellbyte.com
Social
Email ID: *****@cellbyte.com
Phone Number: +49 **********

Key Metrics

Founded Year

2024

Location

Munich, Germany

Stage

Seed

Total Funding

$3.25M in 2 rounds

Latest Funding Round

Seed, Nov 19, 2025, $*****

Investors

Frontline Ventures & 4 more

Ranked

10^th among 110 active competitors

Employee Count

10 as on Mar 31, 2026

Similar Companies

Manifold AI & 112 more

View Cellbyte's full profile

Cellbyte has raised a total funding of $3.25M over 2 rounds. Its latest funding round was a Seed round on Nov 19, 2025 for $*****. 5 investors participated in its latest round. Cellbyte has 5 institutional investors.

Here is the list of recent funding rounds of Cellbyte:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 19, 2025	1579842	Seed	6086109	7962392	2941341	2200253

Access funding benchmarks and valuations. Sign up today!

View details of Cellbyte's funding rounds and investors

The founders of Cellbyte are Samuel Moreira, Felix Steinbrenner and Daniel Moreira.

Here are the details of Cellbyte's key team members:

Samuel Moreira: Co-Founder of Cellbyte.
Felix Steinbrenner: Co-Founder of Cellbyte.
Daniel Moreira: Co-Founder of Cellbyte.

View details of Cellbyte's Founder profiles and Board Members

Cellbyte's employee count trend

Cellbyte has 10 employees as of Mar 26. Here is Cellbyte's employee count trend over the years:

Uncover Cellbyte's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellbyte include Manifold AI, Komodo Health and Owkin. Here is the list of Top 10 competitors of Cellbyte, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	72/100
2nd	Komodo Health 2014, New York City (United States), Series E	AI and cloud-based platforms provide data-driven insights to healthcare providers	$514M	Tiger Global Management, Coatue & 14 others	72/100
3rd	Owkin 2016, Paris (France), Series B	AI generative biology company to create the new standard of biology reasoning	$321M	F-Prime Capital, Frst Capital & 18 others	71/100
4th	Reliant AI 2023, Montreal (Canada), Acquired	Provider of an AI platform for biopharmaceutical research and development	$13.5M	Inovia Capital, Tola Capital & 6 others	58/100
5th	Qureight 2018, Cambridge (United Kingdom), Series B	AI enabled data curation platform for drug development	$31.2M	Molten Ventures, Playfair Capital & 21 others	57/100
6th	Seven Bridges Genomics 2009, Cambridge (United States), Acquired	Biomedical data analysis company accelerating healthcare research with software and analytics	$113M	First Star Ventures, Western Technology Investment ... & 3 others	54/100
7th	Rivia 2002, Switzerland, Series A	Provider of an AI-powered data analytics platform for clinical trials	$18.2M	Earlybird, Speedinvest & 3 others	54/100
8th	IDBS 1989, Guildford (United Kingdom), Acquired	Data management for research teams	$4.96M	Elaia	50/100
9th	Advaita Bioinformatics 2005, Plymouth (United States), Funding Raised	Provider of bioinformatics software tools focused on multi-omics pathway analysis	-	Venture for America, America’s Seed Fund & 4 others	49/100
10th	Cellbyte 2024, Munich (Germany), Seed	AI-driven analytics platform that enables pricing and market access professionals in the pharmaceutical industry	$3.25M	Frontline Ventures, Y Combinator & 3 others	49/100